Details for New Drug Application (NDA): 203978
✉ Email this page to a colleague
The generic ingredient in NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
Summary for 203978
Tradename: | NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE |
Applicant: | Inforlife |
Ingredient: | nicardipine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 203978
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/200ML (0.1MG/ML) | ||||
Approval Date: | Apr 17, 2024 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 40MG/200ML (0.2MG/ML) | ||||
Approval Date: | Apr 17, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription